Vitiligo with raised inflammatory borders: Involvement of T cell immunity and keratinocytes expressing MHC class II and ICAM-1 molecules

European Journal of Dermatology

Volumn 7, Issue 1, 1997, Pages 19-22

  Yagi, Hiroaki ^a   Tokura, Yoshiki ^a   Furukawa, Fukumi ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ICAM 1; keratinocytes; melanocytes; MHC class II; T cells; vitiligo

Indexed keywords

CD8 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; SKIN INFLAMMATION; T LYMPHOCYTE; VITILIGO;

EID: 0031026854     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bolognia JL, Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol 1988; 19: 217-55.
2. Le Poole IC, van den Wijngaard RM, Westerhof W, et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993; 100: 816-22.
3. Hertz KC, Gazze LA, Kirkpatrick CH, Katz SI. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med 1977; 297: 634-7.
4. Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies ana disease activity in vitiligo. J Invest Dermatol 1991; 97: 1078-80.
5. Norris DA, Kissinger RM, Naughton GM, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol 1988; 90: 783-9.
6. Badri AM, Todd PM, Garioch JJ, et al. An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 1993; 170: 149-55.
7. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996; 148: 1219-28.
8. Hann SK, Park YK, Lee KG, et al. Epidermal changes in active vitiligo. J Dermatol 1992; 19: 217-22.
9. Grab J, Wise F. Vitiligo with raised borders. Arch Dermatol Syphilol 1948; 58: 148-53.
10. Buckley WR, Lobitz WC Jr. Vitiligo with a raised inflammatory border. Arch Dermatol Syphilol 1953; 67: 316-20.
11. Michaëlsson G. Vitiligo with raised borders: report of two cases. Acta Derm Venereol 1968; 48: 158-61.
12. Ishii M, Hamada T. Ultrastructural studies of vitiligo with inflammatory raised borders. J Dermatol 1981; 8: 313-22.
13. Tokura Y, Takigawa M, Oku T, Yamada M. Lymphomatoid papulosis. Histologic and immunohistochemical studies in a patient with a scaly pigmented eruption. Arch Dermatol 1986; 122: 1400-5.
14. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline pnosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-29.
15. Bhawan J, Bhutani LK. Keratinocyte damage in vitiligo. J Cutan Pathol 1983; 10: 207-12.
16. Shiohara T, Nickoloff BJ, Sagawa Y, et al. Fixed drug eruption. Expression of epidermal keratinocyte intercellular adhesion molecule-1 (ICAM-1). Arch Dermatol 1989; 125: 1371-6.
17. Acevedo A, Aramburu J, Lopez J, et al. Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 1991; 97: 659-66.
18. Volc-Platzer B, Rappersberger K, Mosberger I, et al. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation. J Invest Dermatol 1988; 91: 162-8.
19. Tokura Y, Yamanaka K, Wakita H, et al. Halo congenital nevus undergoing spontaneous regression. Involvement of T cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies. Arch Dermatol 1994; 130: 1036-41.
20. Al Badri AM, Foulis AK, Todd PM, et al. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol 1993; 169: 203-6.
21. Wakita H, Tokura Y, Furukawa F, Takigawa M. Staphylococcal enterotoxin B upregulates expression of ICAM-1 molecules on IFN-γ-treated keratinocytes and keratinocyte cell lines. J Invest Dermatol 1995; 105: 536-42.
22. Yohn JJ, Critelli M, Lyons MB, Norris DA. Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol 1990; 95: 233-7.
23. Schallreuter KU, Pittelkow MP. Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch Dermatol Res 1988; 280: 137-9.
24. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991 ; 97: 1081-5.